OSE Immunotherapeutics annonce son calendrier financier pour 2026

Nantes, France, 16 mars 2026 – 7h30 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) annonce aujourd’hui son calendrier financier pour 2026.

Early report Major update Updated Mar 16, 2026, 6:30 AM UTC

Track this event Edit in app More event pages

What changed

Early report surfaced from GlobeNewswire Public Companies 1h ago.

First seen Mar 16, 2026, 6:30 AM UTC Latest source Mar 16, 2026, 6:30 AM UTC

Update 1 1h ago

OSE Immunotherapeutics annonce son calendrier financier pour 2026

GlobeNewswire Public Companies •published Mar 16, 2026, 6:30 AM UTC •fetched Mar 16, 2026, 6:40 AM UTC